financetom
Market
financetom
/
Market
/
Sector Update: Financial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sector Update: Financial
Oct 3, 2024 12:38 AM

01:37 PM EDT, 09/23/2024 (MT Newswires) -- Financial stocks were mixed in Monday afternoon trading, with the NYSE Financial Index up 0.1% and the Financial Select Sector SPDR Fund (XLF) off 0.1%.

The Philadelphia Housing Index was rising 0.8%, and the Real Estate Select Sector SPDR Fund (XLRE) was adding 0.6%.

Bitcoin (BTC-USD) was declining 0.7% to $63,199, and the yield for 10-year US Treasuries was little changed at 3.74%.

In economic news, the September flash reading of manufacturing conditions from S&P Global fell to a 15-month low of 47.0 from 47.9 in August, below the 48.6 in a survey compiled by Bloomberg. The services conditions index slid to a two-month low of 55.4 in September from 55.7 in August but was slightly above expectations for 55.2. The composite declined to 54.4 in September from 54.6 in August, a two-month low.

In corporate news, Carlyle-backed (CG) StandardAero is looking to sell 46.5 million shares at an anticipated price of $20 to $23 per share in an initial public offering, the company said in a regulatory filing Monday. Carlyle shares were shedding 0.6%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Third Rock-backed Maze Therapeutics reveals profit in US IPO filing
Third Rock-backed Maze Therapeutics reveals profit in US IPO filing
Jan 7, 2025
Jan 7 (Reuters) - Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its paperwork for a U.S. initial public offering (IPO) filing on Tuesday. The U.S. IPO market has seen an uptick amid falling interest rates, strong equity markets, and hopes of a friendlier regulatory environment under the...
Third Rock-backed Maze Therapeutics reveals profit in US IPO filing
Third Rock-backed Maze Therapeutics reveals profit in US IPO filing
Jan 7, 2025
(Reuters) - Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its paperwork for a U.S. initial public offering (IPO) filing on Tuesday. The U.S. IPO market has seen an uptick amid falling interest rates, strong equity markets, and hopes of a friendlier regulatory environment under the incoming Trump...
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Jan 7, 2025
The U.S. stock market experienced a downturn on Tuesday, with the Nasdaq Composite falling by 1.9% and the S&P 500 dropping by 1.1%. The Dow Jones Industrial Average also declined by 0.4%. These are the top stocks that gained the attention of retail traders and investors throughout the day: Nvidia Corporation ( NVDA )  Nvidia’s stock dropped by 6.22%, closing at $140.14. The stock reached an...
Japan's Nikkei tracks Wall Street lower amid inflation worries
Japan's Nikkei tracks Wall Street lower amid inflation worries
Jan 7, 2025
TOKYO, Jan 8 (Reuters) - Japan's Nikkei share average fell on Wednesday, tracking overnight Wall Street declines after a batch of upbeat U.S. economic data raised concerns that sticky inflation could slow the Federal Reserve's pace of monetary easing. The Nikkei index declined 0.6% to 39,843.84, as of 0153 GMT, with 163 of its 225 components falling, 60 rising and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved